Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05615311
Other study ID # 300010307
Secondary ID
Status Recruiting
Phase Phase 1/Phase 2
First received
Last updated
Start date March 16, 2023
Est. completion date December 2024

Study information

Verified date April 2024
Source University of Alabama at Birmingham
Contact Ariel A. Salas, MD, MSPH
Phone 205-934-4680
Email asalas@uab.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a masked randomized clinical trial in which extremely preterm infants fed human milk will be randomly assigned to receive either the highest (intervention group) or lowest (control group) vitamin D dose recommended during the first 14 days after birth.


Recruitment information / eligibility

Status Recruiting
Enrollment 126
Est. completion date December 2024
Est. primary completion date October 2024
Accepts healthy volunteers No
Gender All
Age group 1 Day to 4 Days
Eligibility Inclusion Criteria: - Gestational age of 28 weeks or less Exclusion Criteria: - Major congenital anomalies and infants - Terminal illness in whom decisions to withhold or limit life support have been made

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Vitamin D supplementation
Study participants assigned to the intervention group will receive 800 IU/ day of vitamin D plus 200-300 IU/day of vitamin D from parenteral and enteral sources during the first 2 weeks after birth.
Other:
No additional vitamin D supplementation
Study participants assigned to the control group will receive 200-300 IU/ day of vitamin D from parenteral and enteral sources during the first 2 weeks after birth.

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Severity of respiratory morbidity A scoring system that defines severity of respiratory morbidity based on the amount of ventilatory support and the need for supplemental oxygen 0 - 120 days
Primary Non-invasive oscillometry (NiOS) measurements of pulmonary mechanics Using the tremoflo N-100 Neo Oscillometry device, we will determine the area under the reactance curve (AX) 40 - 120 days
Secondary Bronchopulmonary dysplasia Number of participants receiving ventilatory support or supplemental oxygen at 36 weeks of postmenstrual age (PMA) or discharge 36 weeks PMA or discharge
See also
  Status Clinical Trial Phase
Completed NCT03641209 - Extremely Low Gestatonal Age Infants' Paracetamol Study Phase 1/Phase 2
Recruiting NCT04114435 - Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
Completed NCT04639583 - Use of NIRS in Preterm Population Born at Altitude N/A
Recruiting NCT04294368 - Targeted Fortification of Donor Breast Milk in Preterm Infants N/A
Completed NCT03504215 - Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health. N/A
Recruiting NCT04735315 - Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
Completed NCT05684419 - Preterm Infants Born to Homeless Mothers.
Recruiting NCT04270240 - A NEW SCORING SYSTEM FOR PREDICTION OF PDA
Completed NCT04535375 - Sonographic QUantification of Venous Circulation In the Preterm Brain N/A
Recruiting NCT05280340 - Anakinra for Preterm Infants Pilot Phase 1/Phase 2
Recruiting NCT05827250 - Vibroacoustic Study of Lung Development in Newborn Infants
Recruiting NCT05824377 - To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation. N/A
Completed NCT03635944 - Nutritional Care and Head Growth in Preterm Infants
Completed NCT03261609 - Risk of Chronic Diseases in Young Adults Born Preterm: Relationship With Inflammation and Oxidative Stress Biomarkers.
Active, not recruiting NCT04325308 - Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk N/A
Active, not recruiting NCT04545866 - The Budesonide in Babies (BiB) Trial Phase 3